Drug profile · INN
crisantaspase
ENRYLAZE
crisantaspase (ENRYLAZE) is a asparagine hydrolytic enzyme. Associated with Jazz Pharmaceuticals Ireland Limited.
EMA: approved Antineoplastic and immunomodulating agents (L01) L01XX02
Patents linked 0
Pipeline programs 5
News articles 0
Drug details — crisantaspase
- Class
- Antineoplastic and immunomodulating agents (L01)
- Route
- —
- Patents
- 0
- Programs
- 5
- Data quality
- 0.89
Quick answer
crisantaspase (ENRYLAZE) is a asparagine hydrolytic enzyme. Associated with Jazz Pharmaceuticals Ireland Limited.
Key facts
INN crisantaspase
Brand ENRYLAZE
Mechanism Asparagine hydrolytic enzyme
Target Asparagine
Therapeutic class Antineoplastic and immunomodulating agents (L01)
ATC code L01XX02
Originator Jazz Pharmaceuticals Ireland Limited
Mechanism of action
Asparagine hydrolytic enzyme
Primary target: Asparagine
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is crisantaspase?
crisantaspase (ENRYLAZE) is a asparagine hydrolytic enzyme. Associated with Jazz Pharmaceuticals Ireland Limited.
What is the brand name for crisantaspase?
ENRYLAZE is a marketed brand name for crisantaspase. Check FDA Drugs@FDA for the current US label holder and prescribing information.